Sanofi (SNYNF) Beginning Cash Balance (2013 - 2026)

Sanofi (SNYNF) posted Beginning Cash Balance of $9.0 billion for Q1 2026, up 3.5% sequentially from $8.7 billion in Q4 2025, and up 14.53% YoY from $7.8 billion in Q1 2025.

Sanofi (SNYNF) Beginning Cash Balance (2013 - 2026) Analysis & Trends

Sanofi (SNYNF) has 7 years of Beginning Cash Balance data on file, last reported at $9.0 billion in Q1 2026.

  • Quarterly Beginning Cash Balance rose 14.53% year-over-year to $9.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.3 billion (up 100.02% YoY) and the FY2025 annual result came in at $8.7 billion, down 6.94% from the prior year.
  • Beginning Cash Balance rose to $9.0 billion in Q1 2026 per SNYNF's latest filing, from $8.7 billion in the prior quarter.
  • The five-year high for Beginning Cash Balance was $9.3 billion in Q4 2024, with the low at $7.8 billion in Q1 2025.
  • Average Beginning Cash Balance over 3 years is $8.7 billion, with a median of $8.7 billion recorded in 2025.
  • Year-over-year, Beginning Cash Balance declined 6.94% in 2025 and increased 14.53% in 2026.
  • Sanofi's Beginning Cash Balance stood at $9.3 billion in 2024, then decreased by 6.94% to $8.7 billion in 2025, then gained by 3.5% to $9.0 billion in 2026.
  • Business Quant data shows SNYNF's Beginning Cash Balance at $9.0 billion in Q1 2026, $8.7 billion in Q4 2025, and $8.7 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Sanofi - - 9.49 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.96 Bn
Mar 31, 2026 8.96 Bn
Dec 31, 2025 8.66 Bn
Dec 31, 2025 8.66 Bn
Sep 30, 2025 8.70 Bn
Sep 30, 2025 8.70 Bn
Mar 31, 2025 7.83 Bn
Mar 31, 2025 7.83 Bn
Dec 31, 2024 9.31 Bn
Dec 31, 2024 9.31 Bn
Jun 30, 2021 -105,834.88 Bn
Jun 30, 2021 -105,834.88 Bn
Mar 31, 2021 106,024.32 Bn
Mar 31, 2021 106,024.32 Bn
Jun 30, 2020 -1,663,983.27 Bn
Jun 30, 2020 -1,663,983.27 Bn
Mar 31, 2020 1,667,738.56 Bn
Mar 31, 2020 1,667,738.56 Bn
Dec 31, 2019 110,688.77
Dec 31, 2019 110,688.77